PKD1 and Parkinson disease: Previous studies from our group suggest that positive modulators of PKD1 signaling could serve as potential neuroprotective agents for the treatment of PD (Asaithambi et al., 2011, 2014; Ay et al., 2015; Bejanin et al., 2017).